-
Je něco špatně v tomto záznamu ?
Botulinum toxin treatment of freezing of gait in Parkinson's disease patients as reflected in functional magnetic resonance imaging of leg movement
M. Vastik, P. Hok, P. Hlustik, P. Otruba, Z. Tüdös, P. Kanovsky,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články
- MeSH
- botulotoxiny terapeutické užití MeSH
- chůze (způsob) MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- neurologické poruchy chůze farmakoterapie etiologie MeSH
- Parkinsonova nemoc farmakoterapie patofyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Freezing of gait (FOG) is a common disabling symptom of (in) Parkinson's disease (PD). The mechanism of FOG is (in) not clearly understood. We investigated the clinical effect and changes of the activity of the sensorimotor system using repeated functional MRI (fMRI) before and after application of botulinum toxin in Parkinson's disease patients with FOG. METHODS: We investigated 20 patients with PD, 10 with FOG and 10 without FOG. PD patients with FOG were treated with intramuscular application of botulinum toxin type A into the tensor fasciae latae muscle bilaterally. The clinical effect of treatment was assessed using FOG questionnaire, "Time up and go" test, UPDRS, Hoehn and Yahr staging, Clinical global impression scale. Activation of the sensorimotor system was studied using BOLD fMRI of the whole brain during repetitive abduction - adduction of each leg interleaved with rest. The clinical (in the FOG group) and imaging (in both groups) examination was repeated after a four-week interval. RESULTS: In the FOG group, the FOG questionnaire has shown a decline of scores after application of botulinum toxin that suggests possible effect of botulinum toxin on freezing of gait. In fMRI results, both groups manifested reduction of the sensorimotor network activated with leg movement, however, the FOG group also showed increased activation in cerebellar vermis and nuclei, in dorsal pons and in medulla after treatment. CONCLUSION: Alleviation of the FOG in PD patients by botulinum toxin seems to be reflected in the functional participation of the cerebellum and its projections as seen by fMRI.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001383
- 003
- CZ-PrNML
- 005
- 20190115103736.0
- 007
- ta
- 008
- 190107s2016 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)27179579
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Vastik, Miroslav $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
- 245 10
- $a Botulinum toxin treatment of freezing of gait in Parkinson's disease patients as reflected in functional magnetic resonance imaging of leg movement / $c M. Vastik, P. Hok, P. Hlustik, P. Otruba, Z. Tüdös, P. Kanovsky,
- 520 9_
- $a BACKGROUND: Freezing of gait (FOG) is a common disabling symptom of (in) Parkinson's disease (PD). The mechanism of FOG is (in) not clearly understood. We investigated the clinical effect and changes of the activity of the sensorimotor system using repeated functional MRI (fMRI) before and after application of botulinum toxin in Parkinson's disease patients with FOG. METHODS: We investigated 20 patients with PD, 10 with FOG and 10 without FOG. PD patients with FOG were treated with intramuscular application of botulinum toxin type A into the tensor fasciae latae muscle bilaterally. The clinical effect of treatment was assessed using FOG questionnaire, "Time up and go" test, UPDRS, Hoehn and Yahr staging, Clinical global impression scale. Activation of the sensorimotor system was studied using BOLD fMRI of the whole brain during repetitive abduction - adduction of each leg interleaved with rest. The clinical (in the FOG group) and imaging (in both groups) examination was repeated after a four-week interval. RESULTS: In the FOG group, the FOG questionnaire has shown a decline of scores after application of botulinum toxin that suggests possible effect of botulinum toxin on freezing of gait. In fMRI results, both groups manifested reduction of the sensorimotor network activated with leg movement, however, the FOG group also showed increased activation in cerebellar vermis and nuclei, in dorsal pons and in medulla after treatment. CONCLUSION: Alleviation of the FOG in PD patients by botulinum toxin seems to be reflected in the functional participation of the cerebellum and its projections as seen by fMRI.
- 650 _2
- $a botulotoxiny $x terapeutické užití $7 D001905
- 650 _2
- $a chůze (způsob) $7 D005684
- 650 _2
- $a neurologické poruchy chůze $x farmakoterapie $x etiologie $7 D020233
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a Parkinsonova nemoc $x farmakoterapie $x patofyziologie $7 D010300
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hok, Pavel $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Hlustik, Petr $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Otruba, Pavel $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Tüdös, Zbyněk $u Department of Radiology, Palacky University Medical School and University Hospital, Czech Republic.
- 700 1_
- $a Kanovsky, Petr $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 37, č. 2 (2016), s. 147-53
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27179579 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190115103947 $b ABA008
- 999 __
- $a ok $b bmc $g 1365231 $s 1039506
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 37 $c 2 $d 147-53 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20190107